Both in Pharmaceuticals
NRX Pharmaceuticals vs Organogenesis Holdings
Over the past year NRXP returned −9.1% and ORGO returned −77.6%; their daily moves had a correlation of 0.00.
NRXP −9.1% ORGO −77.6%Growth of $1, one year, split-adjusted
| Metric | NRXP | ORGO |
|---|---|---|
| Price | $2.49 | $0.8700 |
| Market cap | $107.8M | $111.9M |
| Today | +11.16% | +4.19% |
| 1 month | −15.3% | −35.1% |
| 6 months | −18.4% | −66.0% |
| Year to date | −8.1% | −83.2% |
| 1 year | −12.6% | −78.3% |
| Revenue growth (YoY) | — | −56.7% |
| Gross margin | 38.7% | 100.0% |
| Net margin | −1500.5% | −227.0% |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | 0.2× |
| Net cash | $26.3M | $34.4M |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 61.2% |
| Short % of float | 29.3% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).